Key facts
- This page summarizes Joseph DiTrolio's Form 4 filing for LifeMD, Inc. (LFMD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Aug 2026, 21:24.
Joseph DiTrolio - 11 Aug 2026 Form 4 Insider Report for LifeMD, Inc. (LFMD)
- Reporting relationship
- Director
- Issuer ticker
- LFMD
- Reported as of
- 11 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 Aug 2026, 21:24:45 UTC
- Prior SEC filing
- 06 Oct 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph DiTriolio
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joseph DiTrolio filed Form 4 for LifeMD, Inc. (LFMD) on 13 Aug 2026.
Change
- Previous filing in this sequence was filed on 06 Oct 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001721836
Primary reporting owner
DiTrolio Joseph
- Relationship
- Director
- Address
- C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK
- Signature
- /s/ Joseph DiTriolio
- Signature date
- 13 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LFMD
transaction
Common Stock
Award
- Transaction value
- Shares
- +35,000
- Change %
- +13%
- Price
- $0.000000*
- Shares after
- 308,413
- Date
- 11 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The grant of restricted shares vests on June 1, 2027.